Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?

The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1 year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be monitored with con...

Full description

Saved in:
Bibliographic Details
Published in:Şişli Etfal Hastanesi tıp bülteni 2021-01, Vol.55 (3), p.412-418
Main Authors: Sayar, Suleyman, Gokcen, Pinar, Aykut, Huseyin, Adali, Gupse, Doganay, Hamdi Levent, Ozdil, Kamil
Format: Article
Language:English
Subjects:
Original Research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 418
container_issue 3
container_start_page 412
container_title Şişli Etfal Hastanesi tıp bülteni
container_volume 55
creator Sayar, Suleyman
Gokcen, Pinar
Aykut, Huseyin
Adali, Gupse
Doganay, Hamdi Levent
Ozdil, Kamil
description The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1 year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be monitored with continuous variables from the moment of diagnosis. The aim of this study was to evaluate the diagnostic performance of non-invasive models for determining the prognostic indicators in patients with PBC. Data from patients with PBC were screened retrospectively. Patients were divided into early (≤2) and advanced (≥3) fibrosis groups. In addition, treatment response status according to the Paris-II criteria and liver failure risk (LFR) according to the UK-PBC score were determined. The S-Index consisting of gamma-glutamyltransferase (GGT), platelets (PLT), and albumin, (S-index: 1000×GGT÷[PLT×Albumın2]), other non-invasive models were calculated. The diagnostic effectiveness of non-invasive indicators to determine the fibrosis stage, response to treatment, and low LFR was analyzed. Fifty-three patients were included in the study. The overall mean age at diagnosis was 49.6±13.6 years and 86.8% of the patients ( =46) were female. The S-Index was able to determine fibrosis stage, treatment responded, and patients with low LFR (AUC: 0.747, 0.823, and 0.752; =0.006,
doi_str_mv 10.14744/SEMB.2021.95825
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8526222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2590101779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-991c8748bac6fec2a18aac602584bfae04a468603e6428c36b17d2120142801e3</originalsourceid><addsrcrecordid>eNpVUU1P3DAQtVArQJR7T8hHesjWdpzEuVCVLbQr8SUKZ8txJotRYi-e7Er9Cf3X9e7SFfgyz5p5z_P8CPnM2YTLSsqvvy-uzyeCCT6pCyWKPXLIc6aygov8wwaLrEr4gBwjPrN0Si4qqfbJQS5Tg6nikPydGk_RDYse6E3w2cyvDLoV0EvXxIAO6XVooUf6A0aIg_NA72KY-4Cjs3TmW2fNGCLS0x3B-JY-RDDjAH6k94CL4BG-0NAlqhtM_EPPXe_WdfoUeuPnbnT47RP52Jke4fi1HpHHy4uH6a_s6vbnbPr9KrOiqsesrrlVyUVjbNmBFYYrkyAThZJNZ4BJI0tVshxKKZTNy4ZXrUhueboyDvkROdvqLpbNAK1NS0bT68V2NR2M0-873j3peVhpVYhSCJEETl8FYnhZAo56cGihT04gLFGLomac8aqq0yjbjtr0NRih2z3Dmd6EqNch6nWIehNiopy8XW9H-B9Z_g8T1pnw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2590101779</pqid></control><display><type>article</type><title>Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Sayar, Suleyman ; Gokcen, Pinar ; Aykut, Huseyin ; Adali, Gupse ; Doganay, Hamdi Levent ; Ozdil, Kamil</creator><creatorcontrib>Sayar, Suleyman ; Gokcen, Pinar ; Aykut, Huseyin ; Adali, Gupse ; Doganay, Hamdi Levent ; Ozdil, Kamil</creatorcontrib><description>The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1 year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be monitored with continuous variables from the moment of diagnosis. The aim of this study was to evaluate the diagnostic performance of non-invasive models for determining the prognostic indicators in patients with PBC. Data from patients with PBC were screened retrospectively. Patients were divided into early (≤2) and advanced (≥3) fibrosis groups. In addition, treatment response status according to the Paris-II criteria and liver failure risk (LFR) according to the UK-PBC score were determined. The S-Index consisting of gamma-glutamyltransferase (GGT), platelets (PLT), and albumin, (S-index: 1000×GGT÷[PLT×Albumın2]), other non-invasive models were calculated. The diagnostic effectiveness of non-invasive indicators to determine the fibrosis stage, response to treatment, and low LFR was analyzed. Fifty-three patients were included in the study. The overall mean age at diagnosis was 49.6±13.6 years and 86.8% of the patients ( =46) were female. The S-Index was able to determine fibrosis stage, treatment responded, and patients with low LFR (AUC: 0.747, 0.823, and 0.752; =0.006, &lt;0.001, and 0.0007, respectively). Furthermore, S-Index found to superior to other non-invasive indicators in terms diagnosis of prognostic indicators of PBC. S-index is a practical and inexpensive non-invasive model that can identify liver fibrosis and treatment response in patients with PBC. It can be used as a continuous variable prognostic model in PBC.</description><identifier>ISSN: 1302-7123</identifier><identifier>EISSN: 1308-5123</identifier><identifier>DOI: 10.14744/SEMB.2021.95825</identifier><identifier>PMID: 34712085</identifier><language>eng</language><publisher>Turkey: Kare Publishing</publisher><subject>Original Research</subject><ispartof>Şişli Etfal Hastanesi tıp bülteni, 2021-01, Vol.55 (3), p.412-418</ispartof><rights>Copyright: © 2021 by The Medical Bulletin of Sisli Etfal Hospital.</rights><rights>Copyright: © 2021 by The Medical Bulletin of Sisli Etfal Hospital 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526222/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526222/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34712085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sayar, Suleyman</creatorcontrib><creatorcontrib>Gokcen, Pinar</creatorcontrib><creatorcontrib>Aykut, Huseyin</creatorcontrib><creatorcontrib>Adali, Gupse</creatorcontrib><creatorcontrib>Doganay, Hamdi Levent</creatorcontrib><creatorcontrib>Ozdil, Kamil</creatorcontrib><title>Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?</title><title>Şişli Etfal Hastanesi tıp bülteni</title><addtitle>Sisli Etfal Hastan Tip Bul</addtitle><description>The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1 year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be monitored with continuous variables from the moment of diagnosis. The aim of this study was to evaluate the diagnostic performance of non-invasive models for determining the prognostic indicators in patients with PBC. Data from patients with PBC were screened retrospectively. Patients were divided into early (≤2) and advanced (≥3) fibrosis groups. In addition, treatment response status according to the Paris-II criteria and liver failure risk (LFR) according to the UK-PBC score were determined. The S-Index consisting of gamma-glutamyltransferase (GGT), platelets (PLT), and albumin, (S-index: 1000×GGT÷[PLT×Albumın2]), other non-invasive models were calculated. The diagnostic effectiveness of non-invasive indicators to determine the fibrosis stage, response to treatment, and low LFR was analyzed. Fifty-three patients were included in the study. The overall mean age at diagnosis was 49.6±13.6 years and 86.8% of the patients ( =46) were female. The S-Index was able to determine fibrosis stage, treatment responded, and patients with low LFR (AUC: 0.747, 0.823, and 0.752; =0.006, &lt;0.001, and 0.0007, respectively). Furthermore, S-Index found to superior to other non-invasive indicators in terms diagnosis of prognostic indicators of PBC. S-index is a practical and inexpensive non-invasive model that can identify liver fibrosis and treatment response in patients with PBC. It can be used as a continuous variable prognostic model in PBC.</description><subject>Original Research</subject><issn>1302-7123</issn><issn>1308-5123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVUU1P3DAQtVArQJR7T8hHesjWdpzEuVCVLbQr8SUKZ8txJotRYi-e7Er9Cf3X9e7SFfgyz5p5z_P8CPnM2YTLSsqvvy-uzyeCCT6pCyWKPXLIc6aygov8wwaLrEr4gBwjPrN0Si4qqfbJQS5Tg6nikPydGk_RDYse6E3w2cyvDLoV0EvXxIAO6XVooUf6A0aIg_NA72KY-4Cjs3TmW2fNGCLS0x3B-JY-RDDjAH6k94CL4BG-0NAlqhtM_EPPXe_WdfoUeuPnbnT47RP52Jke4fi1HpHHy4uH6a_s6vbnbPr9KrOiqsesrrlVyUVjbNmBFYYrkyAThZJNZ4BJI0tVshxKKZTNy4ZXrUhueboyDvkROdvqLpbNAK1NS0bT68V2NR2M0-873j3peVhpVYhSCJEETl8FYnhZAo56cGihT04gLFGLomac8aqq0yjbjtr0NRih2z3Dmd6EqNch6nWIehNiopy8XW9H-B9Z_g8T1pnw</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Sayar, Suleyman</creator><creator>Gokcen, Pinar</creator><creator>Aykut, Huseyin</creator><creator>Adali, Gupse</creator><creator>Doganay, Hamdi Levent</creator><creator>Ozdil, Kamil</creator><general>Kare Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?</title><author>Sayar, Suleyman ; Gokcen, Pinar ; Aykut, Huseyin ; Adali, Gupse ; Doganay, Hamdi Levent ; Ozdil, Kamil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-991c8748bac6fec2a18aac602584bfae04a468603e6428c36b17d2120142801e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Original Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sayar, Suleyman</creatorcontrib><creatorcontrib>Gokcen, Pinar</creatorcontrib><creatorcontrib>Aykut, Huseyin</creatorcontrib><creatorcontrib>Adali, Gupse</creatorcontrib><creatorcontrib>Doganay, Hamdi Levent</creatorcontrib><creatorcontrib>Ozdil, Kamil</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Şişli Etfal Hastanesi tıp bülteni</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sayar, Suleyman</au><au>Gokcen, Pinar</au><au>Aykut, Huseyin</au><au>Adali, Gupse</au><au>Doganay, Hamdi Levent</au><au>Ozdil, Kamil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?</atitle><jtitle>Şişli Etfal Hastanesi tıp bülteni</jtitle><addtitle>Sisli Etfal Hastan Tip Bul</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>55</volume><issue>3</issue><spage>412</spage><epage>418</epage><pages>412-418</pages><issn>1302-7123</issn><eissn>1308-5123</eissn><abstract>The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1 year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be monitored with continuous variables from the moment of diagnosis. The aim of this study was to evaluate the diagnostic performance of non-invasive models for determining the prognostic indicators in patients with PBC. Data from patients with PBC were screened retrospectively. Patients were divided into early (≤2) and advanced (≥3) fibrosis groups. In addition, treatment response status according to the Paris-II criteria and liver failure risk (LFR) according to the UK-PBC score were determined. The S-Index consisting of gamma-glutamyltransferase (GGT), platelets (PLT), and albumin, (S-index: 1000×GGT÷[PLT×Albumın2]), other non-invasive models were calculated. The diagnostic effectiveness of non-invasive indicators to determine the fibrosis stage, response to treatment, and low LFR was analyzed. Fifty-three patients were included in the study. The overall mean age at diagnosis was 49.6±13.6 years and 86.8% of the patients ( =46) were female. The S-Index was able to determine fibrosis stage, treatment responded, and patients with low LFR (AUC: 0.747, 0.823, and 0.752; =0.006, &lt;0.001, and 0.0007, respectively). Furthermore, S-Index found to superior to other non-invasive indicators in terms diagnosis of prognostic indicators of PBC. S-index is a practical and inexpensive non-invasive model that can identify liver fibrosis and treatment response in patients with PBC. It can be used as a continuous variable prognostic model in PBC.</abstract><cop>Turkey</cop><pub>Kare Publishing</pub><pmid>34712085</pmid><doi>10.14744/SEMB.2021.95825</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1302-7123
ispartof Şişli Etfal Hastanesi tıp bülteni, 2021-01, Vol.55 (3), p.412-418
issn 1302-7123
1308-5123
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8526222
source Publicly Available Content (ProQuest); PubMed Central
subjects Original Research
title Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A51%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20simple%20Non-Invasive%20Fibrosis%20Models%20Determine%20Prognostic%20Indicators%20(Fibrosis%20and%20Treatment%20Response)%20of%20Primary%20Biliary%20Cholangitis?&rft.jtitle=%C5%9Ei%C5%9Fli%20Etfal%20Hastanesi%20t%C4%B1p%20b%C3%BClteni&rft.au=Sayar,%20Suleyman&rft.date=2021-01-01&rft.volume=55&rft.issue=3&rft.spage=412&rft.epage=418&rft.pages=412-418&rft.issn=1302-7123&rft.eissn=1308-5123&rft_id=info:doi/10.14744/SEMB.2021.95825&rft_dat=%3Cproquest_pubme%3E2590101779%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c279t-991c8748bac6fec2a18aac602584bfae04a468603e6428c36b17d2120142801e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2590101779&rft_id=info:pmid/34712085&rfr_iscdi=true